|
3 weeks 5 days |
Look At Ways In Which Companies Can Develop Pain Drugs & Treatments at Pain Therapeutics 2012 |
|
12 weeks 2 days |
Treating the Whole Family for Adolescent Substance Abuse |
|
14 weeks 4 days |
Anavex to Present Corporate Update at Bio Ceo Investor Conference |
|
20 weeks 2 days |
Parent Choices for Struggling Teens, Reaching the Unreachable Brain |
|
25 weeks 1 day |
Educating the Adolescent Male Brain |
|
26 weeks 3 days |
Exposure To Nature to Rebuild Families |
|
27 weeks 3 days |
Tcg Lifesciences Collaborates with Jswlifesciences in the Area of Central Nervous System |
|
39 weeks 5 days |
Otava Alzheimer’s Disease Targeted Libraries |
|
47 weeks 2 days |
Central Nervous System (CNS) Compound Library from OTAVA |
|
1 year 6 weeks |
ICMS Launches Global Treatment Evaluation for Parkinson’s Disease with a new Sub-Committee for Cell Medicine Oversight |
|
1 year 22 weeks |
HIV Brain Reservoir: Is it the Pandora's Box |
|
1 year 29 weeks |
Thirtieth Anniversary Edition of The Vietnam War novel that made PTSD Real |
|
1 year 50 weeks |
Green Light Affects Circadian Rhythms |
|
1 year 51 weeks |
Continuing Care Retirement Community Introduces Alzheimer’s Training |
|
2 years 6 days |
The Woman’s Quotient organized a Ladies Spa Day for it’s members |
|
2 years 28 weeks |
Detailed analysis of the neurodegenerative disorders market sector |
|
2 years 31 weeks |
Artwork by Justin Canha on Display at Adelphi University’s Gallery |
|
2 years 34 weeks |
ANAVEX contracts FORENAP Pharma for clinical trials of ANAVEX 2-73 in Alzheimer’s disease |
|
2 years 35 weeks |
ANAVEX completes scale-up manufacturing of ANAVEX 2-73 for Phase I Alzheimer’s disease clinical trials |
|
2 years 40 weeks |
Early Registration Deadline for 2009 Magnificent Mile is August 23 |
|
2 years 47 weeks |
Clinilabs and the Epilespy Study Consortium Execute Collaborative Agreement |
|
2 years 48 weeks |
New York Accident Lawyer 866-ATTY-LAW represents victims of Brain Injury |
|
3 years 6 weeks |
Pharmawire: Medivation, Anavex may lower oxidative stress |
|
3 years 23 weeks |
Ground-breaking anti-amnesic and neuroprotective effects of Alzheimer's compound ANAVEX 1-41 published in Journal of Neuropsycho |
|
3 years 24 weeks |
Anavex presents potent neuroprotective effects of Anavex 1-41 at Neuroscience 2008 |
